Showing results (281-290 of 299) with videos related to
Sort By:
Pageof 30
Molecular Cancer Therapeutics|January 8, 2010
Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinomaRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.Blood|May 15, 2010
Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammationBrian M Connolly, Eun Young Choi, Henrik Gårdsvoll, et al.Molecular Carcinogenesis|February 20, 2024
Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivoMengqiu Song, Yingzi Qu, Huajie Jia, et al.Molecular Cancer Research : MCR|April 18, 2009
Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesisRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.Journal of the American Chemical Society|July 13, 2019
Open-Shell Nonbenzenoid Nanographenes Containing Two Pairs of Pentagonal and Heptagonal RingsJunzhi Liu, Shantanu Mishra, Carlo A Pignedoli, et al.Bioorganic & Medicinal Chemistry|June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell deathPing Jun Zhu, John P Hobson, Noel Southall, et al.Antimicrobial Agents and Chemotherapy|October 20, 2010
Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthraxKeith L Wycoff, Archana Belle, Dorothée Deppe, et al.The Journal of Biological Chemistry|November 3, 2007
Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculatureShihui Liu, Hailun Wang, Brooke M Currie, et al.Proceedings of the National Academy of Sciences of the United States of America|July 22, 2022
Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteasesNadire Duru, Nisha R Pawar, Erik W Martin, et al.Translational Oncology|October 27, 2015
Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)Amira Bekdash, Manal Darwish, Zahra Timsah, et al.Pageof 30